2 weeks Ago By ABMN Staff
Rhumbline Advisers lowered its stake in Outset Medical, Inc. ( NASDAQ:OM – Free Report ) by 67.6% in the 2nd quarter, Holdings Channel.
com reports. The firm owned 22,418 shares of the company’s stock after selling 46,699 shares during the period. Rhumbline Advisers’ holdings in Outset Medical were worth $86,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of OM. State Board of Administration of Florida Retirement System grew its stake in Outset Medical by 33.4% during the 1st quarter.
State Board of Administration of Florida Retirement System now owns 18,842 shares of the company’s stock worth $42,000 after buying an additional 4,720 shares during the last quarter. Summit Securities Group LLC acquired a new position in Outset Medical during the second quarter worth about $105,000. Price T Rowe Associates Inc.
MD raised its position in Outset Medical by 75.3% in the first quarter. Price T Rowe Associates Inc.
MD now owns 82,636 shares of the company’s stock worth $184,000 after acquiring an additional 35,495 shares in the last quarter. Griffin Asset Management Inc. lifted its holdings in Outset Medical by 5.
7% in the 1st quarter. Griffin Asset Management Inc. now owns 97,914 shares of the company’s stock valued at $217,000 after acquiring an additional 5,300 shares during the last quarter.
Finally, Jacobs Levy Equity Management Inc. increased its holdings in shares of Outset Medical by 29.7% in the first quarter.
Jacobs Levy Equity Management Inc. now owns 398,006 shares of the company’s stock valued at $884,000 after buying an additional 91,256 shares in the last quarter. Wall Street Analysts Forecast Growth Several equities research analysts recently commented on OM shares.
Royal Bank of Canada downgraded shares of Outset Medical from an “outperform” rating to a “sector perform” rating and reduced their price target for the company from $6.00 to $3.00 in a research report on Thursday, August 8th.
TD Cowen cut their target price on Outset Medical from $9.00 to $3.00 and set a “buy” rating on the stock in a report on Thursday, August 8th.
One research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $4.64.
Outset Medical Stock Performance Shares of NASDAQ OM opened at $0.68 on Tuesday. The company has a market cap of $35.
26 million, a P/E ratio of -0.20 and a beta of 1.92.
Outset Medical, Inc. has a 12 month low of $0.44 and a 12 month high of $10.
77. The business’s 50 day moving average is $1.34 and its two-hundred day moving average is $2.
59. The company has a quick ratio of 5.38, a current ratio of 6.
80 and a debt-to-equity ratio of 2.87. Outset Medical ( NASDAQ:OM – Get Free Report ) last announced its quarterly earnings results on Wednesday, August 7th.
The company reported ($0.66) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.59) by ($0.
07). The business had revenue of $27.39 million during the quarter, compared to the consensus estimate of $31.
19 million. Outset Medical had a negative net margin of 136.72% and a negative return on equity of 143.
52%. During the same period last year, the firm earned ($0.90) EPS.
On average, equities analysts expect that Outset Medical, Inc. will post -2.52 EPS for the current year.
About Outset Medical ( Free Report ) Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. Further Reading Want to see what other hedge funds are holding OM? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Outset Medical, Inc. ( NASDAQ:OM – Free Report ). Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.
com's FREE daily email newsletter ..
